Our Therapeutic Centers of Excellence
Veristat has supported over 560 Oncology projects across a multitude of solid tumor and hematologic malignancy indications.
Veristat has conducted more than 250 Infectious Disease projects for products that prevent or combat viral, bacterial, fungal, or parasitic infections.
Veristat has partnered with clients to advance countless products through clinical development for Neurology and CNS disorders that have no cure or limited treatment options available today.
Veristat has supported breakthrough therapies that treat and manage cardiovascular disease, the leading killer of people today.
Veristat is proud to have worked on nearly 600 rare disease projects across a diverse range of indications.
Whether you need to keep a current program on track or are trying to fast-track a COVID-19 diagnostic, treatment, or vaccine we can help you navigate the ever-changing environment.